期刊
AMERICAN JOURNAL OF HUMAN GENETICS
卷 108, 期 8, 页码 1385-1400出版社
CELL PRESS
DOI: 10.1016/j.ajhg.2021.05.015
关键词
-
资金
- Cambridge AMD Study (UK Medical Research Council) [G0000067]
- Reading Centre, Moorfields Eye Hospital, London
- Centre for Inherited Disease Research in Baltimore, MD [HHSN268201200008I]
- Case Western Reserve University, Cleveland [EY022310]
- University of Michigan, Department of Biostatistics [1x01HG006934-01]
- Medical Research Council [MR/P025838/1, MR/M008959/1]
- Helmut Ecker Foundation, Germany
- MRC [MR/M008959/1] Funding Source: UKRI
The study revealed that mutations at the complement factor H (CFH) locus may lead to elevated concentrations of circulating FHR proteins, which could be major drivers of AMD. These findings support the need for research into FHR protein modulation as a potential therapeutic avenue for AMD.
Age-related macular degeneration (AMD) is a leading cause of vision loss; there is strong genetic susceptibility at the complement factor H (CFH) locus. This locus encodes a series of complement regulators: factor H (FH), a splice variant factor-H-like 1 (FHL-1), and five factorH-related proteins (FHR-1 to FHR-5), all involved in the regulation of complement factor C3b turnover. Little is known about how AMDassociated variants at this locus might influence FHL-1 and FHR protein concentrations. We have used a bespoke targeted mass-spectrometry assay to measure the circulating concentrations of all seven complement regulators and demonstrated elevated concentrations in 352 advanced AMD-affected individuals for all FHR proteins (FHR-1, p = 2.4 x 10(-10); FHR-2, p = 6.0 x 10(-10); FHR-3, p = 1.5 x 10(-5); FHR-4, p = 1.3 x 10(-3); FHR-5, p = 1.9 3 10(-4)) and FHL-1 (p = 4.9 3 10(-4)) when these individuals were compared to 252 controls, whereas no difference was seen for FH (p = 0.94). Genome-wide association analyses in controls revealed genome-wide-significant signals at the CFH locus for all five FHR proteins, and univariate Mendelian-randomization analyses strongly supported the association of FHR-1, FHR-2, FHR-4, and FHR-5 with AMD susceptibility. These findings provide a strong biochemical explanation for how genetically driven alterations in circulating FHR proteins could be major drivers of AMD and highlight the need for research into FHR protein modulation as a viable therapeutic avenue for AMD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据